BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 33214900)

  • 21. Spatio-temporal evolution and trend prediction of the incidence of Class B notifiable infectious diseases in China: a sample of statistical data from 2007 to 2020.
    Wang RN; Zhang YC; Yu BT; He YT; Li B; Zhang YL
    BMC Public Health; 2022 Jun; 22(1):1208. PubMed ID: 35715790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spatial distribution of 12 class B notifiable infectious diseases in China: A retrospective study.
    Zhu B; Fu Y; Liu J; Mao Y
    PLoS One; 2018; 13(4):e0195568. PubMed ID: 29621351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changing spatiotemporal patterns for hepatitis of unspecified aetiology in China, 2004-2021: a population-based surveillance study.
    Zhao N; Guo X; Wang L; Zhou H; Gong L; Miao Z; Chen Y; Qin S; Yu Z; Liu S; Wang S
    Front Public Health; 2023; 11():1177965. PubMed ID: 37213628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiologic changes of infectious diseases in the post-SARS era in China, 2004-2018.
    Luo Y; Wu B; Xu Y; Ai L; Lv H; Wu J; Tan W
    BMC Public Health; 2023 Nov; 23(1):2171. PubMed ID: 37932712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Annual incidence and fatality rates of notifiable infectious diseases in southeast China from 1950 to 2022 and relationship to socioeconomic development.
    Hu J; Li W; Peng Z; Chen Z; Shi Y; Zheng Y; Liang Q; Wu Y; Liu W; Shen W; Dai Q; Zhu L; Bao C; Zhu F; Chen F
    J Glob Health; 2023 Sep; 13():04107. PubMed ID: 37681663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Surveillance on other infectious diarrheal diseases in China from 2014 to 2015].
    Zhang P; Zhang J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Apr; 38(4):424-430. PubMed ID: 28468056
    [No Abstract]   [Full Text] [Related]  

  • 27. Analysis of spatial-temporal distribution of notifiable respiratory infectious diseases in Shandong Province, China during 2005-2014.
    Li X; Chen D; Zhang Y; Xue X; Zhang S; Chen M; Liu X; Ding G
    BMC Public Health; 2021 Aug; 21(1):1597. PubMed ID: 34461855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Dramatic achievements in infectious disease prevention and treatment in China during the past 70 years].
    Yang WZ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Dec; 40(12):1493-1498. PubMed ID: 32062906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interrupted time series analysis using the ARIMA model of the impact of COVID-19 on the incidence rate of notifiable communicable diseases in China.
    Zhou Q; Hu J; Hu W; Li H; Lin GZ
    BMC Infect Dis; 2023 Jun; 23(1):375. PubMed ID: 37316780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Trend of epidemics and variation of pathogens of hand, foot and mouth disease in China: a dynamic series analysis, 2008-2017].
    Zhang J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Feb; 40(2):147-154. PubMed ID: 30744263
    [No Abstract]   [Full Text] [Related]  

  • 31. Infectious diseases in Poland in 2014.
    Sadkowska-Todys MA; Zieliński A; Czarkowski MS
    Przegl Epidemiol; 2016; 70(2):167-181. PubMed ID: 27779831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infectious diseases in Poland in 2016.
    Sadkowska-Todys M; Zieliński A; Czarkowski MP
    Przegl Epidemiol; 2018; 72(2):129-141. PubMed ID: 30111085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013.
    Johnson NB; Hayes LD; Brown K; Hoo EC; Ethier KA;
    MMWR Suppl; 2014 Oct; 63(4):3-27. PubMed ID: 25356673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The indirect impacts of nonpharmacological COVID-19 control measures on other infectious diseases in Yinchuan, Northwest China: a time series study.
    Liu W; Wang R; Li Y; Zhao S; Chen Y; Zhao Y
    BMC Public Health; 2023 Jun; 23(1):1089. PubMed ID: 37280569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The COVID-19 epidemic and other notifiable infectious diseases in China.
    Bai BK; Jiang QY; Hou J
    Microbes Infect; 2022 Feb; 24(1):104881. PubMed ID: 34419605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Epidemiological characteristics of severe cases of hand, foot, and mouth disease in China, 2008-2018].
    Ren MR; Cui JZ; Nie TR; Liu FF; Sun JL; Zhang YW; Chang ZR
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Nov; 41(11):1802-1807. PubMed ID: 33297642
    [No Abstract]   [Full Text] [Related]  

  • 37. Morbidity Analysis of the Notifiable Infectious Diseases in China, 2018.
    Dong S; Ren X; Zhang C; Geng M; Zhu Y; Shi L; Zhang L; Li Z; Wang L
    China CDC Wkly; 2019 Dec; 1(4):47-53. PubMed ID: 34594603
    [No Abstract]   [Full Text] [Related]  

  • 38. Epidemiological Trends and Hotspots of Other Infectious Diarrhea
    Chen C; Guan Z; Huang C; Jiang D; Liu X; Zhou Y; Yan D; Zhang X; Zhou Y; Ding C; Lan L; Lin Y; Wu J; Li L; Yang S
    Front Public Health; 2021; 9():679853. PubMed ID: 34368054
    [No Abstract]   [Full Text] [Related]  

  • 39. Trends in notifiable infectious diseases in China: implications for surveillance and population health policy.
    Zhang L; Wilson DP
    PLoS One; 2012; 7(2):e31076. PubMed ID: 22359565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Analysis of reported infectious diarrhea (other than cholera, dysentery, typhoid and paratyphoid) in China in 2011].
    Liu HX; Zhang J
    Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Apr; 47(4):328-32. PubMed ID: 23928638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.